BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35435201)

  • 21. Comprehensive analysis of parotid mass: A retrospective study of 369 cases.
    Comoglu S; Ozturk E; Celik M; Avci H; Sonmez S; Basaran B; Kiyak E
    Auris Nasus Larynx; 2018 Apr; 45(2):320-327. PubMed ID: 28473271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary salivary gland tumors in eastern Nepal tertiary care hospital.
    Nepal A; Chettri ST; Joshi RR; Bhattarai M; Ghimire A; Karki S
    J Nepal Health Res Counc; 2010 Apr; 8(1):31-4. PubMed ID: 21879011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of benign and malignant parotid gland tumors: A retrospective study of 992 patients.
    Lee DH; Jung EK; Lee JK; Lim SC
    Am J Otolaryngol; 2023; 44(2):103690. PubMed ID: 36473266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parotid gland tumors: a retrospective study of 154 patients.
    Maahs GS; Oppermann Pde O; Maahs LG; Machado Filho G; Ronchi AD
    Braz J Otorhinolaryngol; 2015; 81(3):301-6. PubMed ID: 25934418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinicopathologic study of parotid gland tumors.
    Chidzonga MM; Lopez Perez VM; Portilla Alvarez AL
    J Oral Maxillofac Surg; 1994 Dec; 52(12):1253-6. PubMed ID: 7965327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical presentation and outcome of parotid gland tumours.
    Shah SA; Riaz U; Zubair M; Saaiq M
    J Coll Physicians Surg Pak; 2013 Sep; 23(9):625-8. PubMed ID: 24034185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low intensity whole-body oxidative stress in patients with parotid gland tumors.
    Sowa P; Kasperczyk S; Dadok A; Misiołek M; Adamczyk-Sowa M
    Otolaryngol Pol; 2022 Dec; 77(1):1-5. PubMed ID: 36805514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Performance of the magnetic resonance imaging in parotid gland tumor histopathology].
    Masmoudi M; Hasnaoui M; Guizani R; Lahmar R; Jerbi S; Mighri K
    Pan Afr Med J; 2021; 39():10. PubMed ID: 34178238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Our experience in the treatment of the tumors of parotid gland].
    Rossi Izquierdo M; Frade González C; Cabanas Rodríguez E; Dios Loureiro C; Lozano Ramírez A; Labella Caballero T
    An Otorrinolaringol Ibero Am; 2007; 34(3):257-71. PubMed ID: 17725170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Masses of the salivary gland region in children.
    Bentz BG; Hughes CA; Lüdemann JP; Maddalozzo J
    Arch Otolaryngol Head Neck Surg; 2000 Dec; 126(12):1435-9. PubMed ID: 11115277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results.
    Karaman CZ; Tanyeri A; Özgür R; Öztürk VS
    Dentomaxillofac Radiol; 2021 May; 50(4):20200391. PubMed ID: 33237812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current management of benign parotid tumors--the role of limited superficial parotidectomy.
    O'Brien CJ
    Head Neck; 2003 Nov; 25(11):946-52. PubMed ID: 14603455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferative activity as detected by immunostaining with Ki-67 and proliferating cell nuclear antigen in benign and malignant epithelial lesions of the human parotid gland.
    Zhu Q; Tipoe GL; White FH
    Anal Quant Cytol Histol; 1999 Aug; 21(4):336-42. PubMed ID: 10560511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of Sonographic Criteria for Reliable Identification of T1-T2 Low-Grade Malignant Tumors of the Parotid Gland.
    Berner F; Koch M; Müller SK; Schapher M; Grundtner P; Iro H; Mantsopoulos K
    Ultrasound Med Biol; 2021 Mar; 47(3):471-477. PubMed ID: 33309444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of ultrasound in the assessment of benignity and malignancy of parotid masses.
    Wu S; Liu G; Chen R; Guan Y
    Dentomaxillofac Radiol; 2012 Feb; 41(2):131-5. PubMed ID: 22116132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T2 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging for the differentiation of parotid gland tumors.
    Baohong W; Jing Z; Zanxia Z; Kun F; Liang L; Eryuan G; Yong Z; Fei H; Jingliang C; Jinxia Z
    Eur J Radiol; 2022 Jun; 151():110265. PubMed ID: 35472650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased neutrophil lymphocyte ratio and platelet lymphocyte ratio in malignant parotid tumors.
    Kuzucu İ; Güler İ; Kum RO; Baklacı D; Özcan M
    Braz J Otorhinolaryngol; 2020; 86(1):105-110. PubMed ID: 31122885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Color Doppler ultrasound studies of parotid tumors].
    Benzel W; Zenk J; Iro H
    HNO; 1995 Jan; 43(1):25-30. PubMed ID: 7890547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salivary Gland Tumors: A Clinicopathologic Analysis From Taipei Veterans General Hospital.
    Liao WC; Chih-Chao C; Ma H; Hsu CY
    Ann Plast Surg; 2020 Jan; 84(1S Suppl 1):S26-S33. PubMed ID: 31833885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of fine needle aspiration biopsy in deep lobe parotid tumors: Comparison of preoperative cytology and postoperative histopathologic results.
    Seyhun N; Doğan U; Çalış ZAB; Kaya MF; Hasçiçek SÖ; Turgut S
    Am J Otolaryngol; 2021; 42(1):102590. PubMed ID: 33045535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.